SEATTLE BIOMEDICAL RESEARCH INSTITUTE: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization
SEATTLE BIOMEDICAL RESEARCH INSTITUTE (EIN 91-0961784)
Tax period
2014-07-01 to 2015-06-30
Filed
2016-02-15
IRS object ID
201620469349300722
Schema version
2014v6.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-02-15T11:36:04-06:00ReturnTs
Tax Period End2015-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN910189318PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1MOSS ADAMS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1999 THIRD AVENUE SUITE 2800AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98104ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2014-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN910961784EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SEATTLE BIOMEDICAL RESEARCH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlSEATBusinessNameControlTxt
Phone2062567200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVENUE NORTH NO 500AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP981095219ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonLOUIS COFFMANPersonNm
Person TitleSR VP-STRATEGY/BUSINESS DEVTPersonTitleTxt
Phone2062567200PhoneNum
Signature2016-02-10SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonANGELA M FIDLERPreparerPersonNm
PTINP01254538PTIN
Phone2063026500PhoneNum
Preparation2016-02-10PreparationDt
FieldValueIRS element (for citing)
Tax2014TaxYr
Build TS2016-08-17 19:52:53ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1CENTER FOR INFECTIOUS DISEASE RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerALAN ADEREMPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVENUE NORTH NO 500AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP981095219ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$38,060,963GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CIDRESEARCH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1976FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionTO ELIMINATE THE WORLD'S MOST DEVASTATING INFECTIOUS DISEASES.ActivityOrMissionDesc
Voting Members Governing Body21VotingMembersGoverningBodyCnt
Voting Members Independent19VotingMembersIndependentCnt
Total Employee309TotalEmployeeCnt
Total Volunteers20TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$34,292,693PYContributionsGrantsAmt
CY Contributions Grants$31,681,918CYContributionsGrantsAmt
PY Program Service Revenue$469,073PYProgramServiceRevenueAmt
CY Program Service Revenue$184,105CYProgramServiceRevenueAmt
PY Investment Income-$91,869PYInvestmentIncomeAmt
CY Investment Income$2,635,549CYInvestmentIncomeAmt
PY Other Revenue$479,187PYOtherRevenueAmt
CY Other Revenue$1,096,900CYOtherRevenueAmt
PY Total Revenue$35,149,084PYTotalRevenueAmt
CY Total Revenue$35,598,472CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$18,003,859PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$16,268,338CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$108,289CYTotalFundraisingExpenseAmt
PY Other Expenses$20,226,768PYOtherExpensesAmt
CY Other Expenses$18,329,696CYOtherExpensesAmt
PY Total Expenses$38,230,627PYTotalExpensesAmt
CY Total Expenses$34,598,034CYTotalExpensesAmt
PY Revenues Less Expenses-$3,081,543PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,000,438CYRevenuesLessExpensesAmt
Total Assets BOY$21,235,288TotalAssetsBOYAmt
Total Assets EOY$46,633,100TotalAssetsEOYAmt
Total Liabilities BOY$10,317,568TotalLiabilitiesBOYAmt
Total Liabilities EOY$8,580,767TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$10,917,720NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$38,052,333NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEATTLE BIOMEDICAL RESEARCH INSTITUTE IS THE LARGEST NONPROFIT INDEPENDENT RESEARCH INSTITUTE IN THE WORLD FOCUSED SOLELY ON INFECTIOUS DISEASE RESEARCH. OUR MISSION IS TO ELIMINATE THE WORLD'S MOST DEVASTATING INFECTIOUS DISEASES. THE INSTITUTE INTEGRATES SYSTEMS BIOLOGY WITH MORE TRADITIONAL BIOLOGY TO DEVELOP A DEEPER UNDERSTANDING OF THE HUMAN IMMUNE SYSTEM AND INFECTIOUS DISEASE PATHOGENESIS. OUR RESEARCH PROGRAMS AIM TO MAKE TRANSFORMATIVE ADVANCES THAT PROVIDE A MORE COMPREHENSIVE EXPLANATION OF THE MYSTERIES OF THE INTERACTION BETWEEN PATHOGENS AND THE HUMAN IMMUNE SYSTEM THEREBY TO ACCELERATE PROGRESS ON THE DEVELOPMENTS OF VACCINES TO PREVENT AND DRUGS TO TREAT AND, WE HOPE ONE DAY, CURE INFECTIOUS DISEASES ULTIMATELY TO SAVE THE LIVES OF THE 14 MILLION PEOPLE WHO WILL OTHERWISE DIE EACH YEAR FROM MALARIA, HIV/AIDS, TUBERCULOSIS AND OTHER DREADED INFECTIOUS DISEASES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$30,837,044ExpenseAmt
Revenue$184,105RevenueAmt
DescOUR VALUE PROPOSITION IS TO (I) INFLUENCE... TO CREATE, USE AND SHARE NEW KNOWLEDGE; (II) INVENT... APPLY THAT KNOWLEDGE TO DEVELOP NEW TOOLS, MATERIALS AND METHODS USEFUL TO ENABLE AND FACILITATE RESEARCH ON THE CRITICAL PATH TO PREVENT, DIAGNOSE AND TREAT DISEASE; AND (III) EDUCATE... TRAIN THE NEXT GENERATION OF SCIENTISTS WHO WILL ADD SCIENTIFIC, RESEARCH AND CLINICAL CAPACITY IN THE DEVELOPING WORLD.ACCOMPLISHMENTS INCLUDE:* DISCOVERY OF RNA EDITING, WHICH PROVIDES A POTENTIAL BASIS FOR DRUG TREATMENTS FOR THREE MAJOR PARASITIC DISEASES.* IDENTIFIED TWO HIV-1 ENVELOPE ANTIGENS THAT ELICITED BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV WHEN INTRODUCED AS A TRIAL VACCINE IN PRIMATES.* DEVELOPED A PROMISING GENETICALLY ATTENUATED PARASITE (GAP) MALARIA VACCINE HAS PROVEN 100 PERCENT PROTECTIVE, 100 PERCENT OF THE TIME IN MOUSE STUDIES. PHASE I CLINICAL SAFETY TRIALS - THE FIRST TESTS IN HUMAN VOLUNTEERS - ARE CURRENTLY UNDERWAY FOR THIS VACCINE. * LED TO THE IDENTIFICATION OF AN UNUSUAL ARRANGEMENT OF GENES IN LEISHMANIA. AFTER A THREE-YEAR EFFORT, INSTITUTE SCIENTISTS DEVELOPED A WAY TO TURN THESE GENES ON AND OFF, ALLOWING THE STUDY OF THE ROLES SPECIFIC LEISHMANIA GENES PLAY IN CAUSING DISEASE.* AS PART OF AN INTERNATIONAL CONSORTIUM, SEATTLE BIOMED RESEARCHERS SEQUENCED THE GENOMES OF THE PARASITES THAT CAUSE AFRICAN SLEEPING SICKNESS, CHAGAS' DISEASE AND LEISHMANIASIS, PROVIDING THE BASIS FOR NEW DRUGS AND TREATMENTS.* THE INSTITUTE REACHED A SIGNIFICANT MILESTONE BY DETERMINING NEARLY 1,000 PROTEIN STRUCTURES FROM INFECTIOUS DISEASE ORGANISMS. THESE PROTEIN STRUCTURES CAN HELP RESEARCHERS FIND POTENTIAL TARGETS FOR NEW DRUGS, ESSENTIAL ENZYMES AND POSSIBLE VACCINE CANDIDATES. * THE INSTITUTE OPERATES A MALARIA CLINICAL TRIALS CENTER, ONE OF ONLY FOUR CENTERS IN THE WORLD THAT CAN SAFELY AND EFFECTIVELY TEST NEW MALARIA TREATMENTS AND VACCINES IN HUMANS THROUGH THE MALARIA HUMAN CHALLENGE MODEL.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$371,885ExpenseAmt
DescBIOQUEST: THE PRIMARY GOAL OF THE INSTITUTE'S SCIENCE OUTREACH PROGRAM, BIOQUEST, IS TO PROVIDE A CURRICULUM-RELEVANT, CAREER-INSPIRING, TECHNOLOGY-RICH SCIENCE EDUCATION PROGRAM WITHIN THE CONTEXT OF INFECTIOUS DISEASE RESEARCH TO HIGH SCHOOL STUDENTS, TEACHERS, AND THE GENERAL PUBLIC. WE ARE THE ONLY ORGANIZATION IN THE NATION TO OFFER A 32-PERSON TEACHING LAB, WITHIN THE FOOTPRINT OF AN INFECTIOUS DISEASE RESEARCH INSTITUTE.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$31,208,929TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan OutstandingYes (1)LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document45IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee309EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members21GoverningBodyVotingMembersCnt
Independent Voting Member19IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint VentureYes (1)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (1)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LOUIS COFFMANBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2062567200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVE N 500AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP981095219ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ALAN ADEREM PHD
PRESIDENT40.00Yes (X)Yes (X)$318,268$0$38,899
MARK ASHIDA
CHAIR/ TRUSTEE3.00Yes (X)Yes (X)$0$0$0
KEVIN KELLY JD
VICE CHAIR/ TRUSTEE3.00Yes (X)Yes (X)$0$0$0
GREGG BLODGETT
TREASURER/ TRUSTEE3.00Yes (X)Yes (X)$0$0$0
STEVEN CLIFFORD
SECRETARY/ TRUSTEE3.00Yes (X)Yes (X)$0$0$0
TREVOR MOODY
IMMEDIATE PAST CHAIR3.00Yes (X)$0$0$0
KEN STUART PHD
PRESIDENT EMERITUS/ TRUSTEE40.00Yes (X)$294,519$0$32,500
ROSEMARY BARKER ARAGON
TRUSTEE3.00Yes (X)$0$0$0
PATRICE AULD
TRUSTEE3.00Yes (X)$0$0$0
RICHARD BEAR
TRUSTEE3.00Yes (X)$0$0$0
ALAN LEVY PHD
TRUSTEE3.00Yes (X)$0$0$0
NEIL MCDONNELL PHARMD
TRUSTEE3.00Yes (X)$0$0$0
BRIAN OLSAVSKY
TRUSTEE3.00Yes (X)$0$0$0
TODD PATRICK
TRUSTEE3.00Yes (X)$0$0$0
TJ PETRIZZO
TRUSTEE3.00Yes (X)$0$0$0
CHRISTOPHER H PORTER PHD
TRUSTEE3.00Yes (X)$0$0$0
ALEXANDRE PORTET
TRUSTEE3.00Yes (X)$0$0$0
BRIAN SCHWARTZ
TRUSTEE3.00Yes (X)$0$0$0
DAVID R STEWART JD
TRUSTEE3.00Yes (X)$0$0$0
MOYA VAZQUEZ
TRUSTEE3.00Yes (X)$0$0$0
BRYAN WHITE
TRUSTEE3.00Yes (X)$0$0$0
RANDALL HASSLER
COO/VP40.00Yes (X)$188,034$0$28,637
LOUIS COFFMAN
SR. VP-STRATEGY/ BUSINESS DEVELOPMENT40.00Yes (X)$272,354$0$39,202
STEFAN KAPPE PHD
PRINCIPAL INVESTIGATOR40.00$187,468$0$27,745Yes (X)
PETER MYLER PHD
PRINCIPAL INVESTIGATOR40.00$160,892$0$28,235Yes (X)
LEONIDAS STAMATATOS PHD
PRINCIPAL INVESTIGATOR40.00$187,974$0$24,145Yes (X)
SUSAN P BROWN
VP ADVANCEMENT40.00$162,141$0$0Yes (X)
JOHN D AITCHISON
PRINCIPAL INVESTIGATOR40.00$161,284$0$29,247Yes (X)
RUOBING WANG
PRINCIPAL INVESTIGATOR40.00$151,415$0$22,437Yes (X)
MALCOLM J GARDNER
PRINCIPAL INVESTIGATOR40.00$147,017$0$21,998Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,231,366TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$293,045TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K20IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
UNIVERSITY OF WASHINGTON GRANTS & CONTRA
12455 COLLECTIONS DRIVECHICAGOIL60693RESEARCH$2,093,062
BERYLLIUM DISCOVERY CORP
3 PRESTON COURTBEDFORDMA01730RESEARCH$1,993,151
THE SCRIPPS RESEARCH INSTITUTE
10550 N TORRY PINES ROADLA JOLLACA92037RESEARCH$1,275,334
INSTITUTE FOR SYSTEMS BIOLOGY
401 TERRY AVE NSEATTLEWA98109RESEARCH$1,174,330
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FARIVIEW AVE NSEATTLEWA98109RESEARCH$525,193
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K15CntrctRcvdGreaterThan100KCnt
Government Grants$23,417,934GovernmentGrantsAmt
All Other Contributions$8,263,984AllOtherContributionsAmt
Total Contributions$31,681,918TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
RESEARCH SUPPORT SRVCS541900$131,451$131,451
PROGRAM SERVICE FEES541900$52,654$52,654
FieldValueIRS element (for citing)
Total Program Service Revenue$184,105TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,771,008TotalRevenueColumnAmt
Exclusion$2,771,008ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$2,274,798RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$2,265,198RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$9,600RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$9,600TotalRevenueColumnAmt
Exclusion$9,600ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Other$61,834OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Other$197,293OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Other-$135,459OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$135,459TotalRevenueColumnAmt
Exclusion-$135,459ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescWESTLAKE LLCDesc
Business900099BusinessCd
Total Revenue Column$1,087,300TotalRevenueColumnAmt
Exclusion$1,087,300ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$1,087,300OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$35,598,472TotalRevenueColumnAmt
Related Or Exempt Func Income$184,105RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$3,732,449ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,221,500TotalAmt
Program Services$777,251ProgramServicesAmt
Management And General$444,249ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$11,360,796TotalAmt
Program Services$10,582,755ProgramServicesAmt
Management And General$740,026ManagementAndGeneralAmt
Fundraising$38,015FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$879,024TotalAmt
Program Services$825,543ProgramServicesAmt
Management And General$50,492ManagementAndGeneralAmt
Fundraising$2,989FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,731,522TotalAmt
Program Services$1,197,474ProgramServicesAmt
Management And General$530,013ManagementAndGeneralAmt
Fundraising$4,035FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,075,496TotalAmt
Program Services$974,301ProgramServicesAmt
Management And General$97,908ManagementAndGeneralAmt
Fundraising$3,287FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$1,040,044TotalAmt
Program Services$645,962ProgramServicesAmt
Management And General$378,105ManagementAndGeneralAmt
Fundraising$15,977FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$144,557TotalAmt
Program Services$27,569ProgramServicesAmt
Management And General$116,876ManagementAndGeneralAmt
Fundraising$112FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$98,056TotalAmt
Program Services$86,813ProgramServicesAmt
Management And General$10,844ManagementAndGeneralAmt
Fundraising$399FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$769,311TotalAmt
Program Services$716,133ProgramServicesAmt
Management And General$34,940ManagementAndGeneralAmt
Fundraising$18,238FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$38,866TotalAmt
Program Services$37,926ProgramServicesAmt
Management And General$761ManagementAndGeneralAmt
Fundraising$179FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$334,570TotalAmt
Program Services$298,998ProgramServicesAmt
Management And General$31,615ManagementAndGeneralAmt
Fundraising$3,957FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$405,927TotalAmt
Program Services$340,675ProgramServicesAmt
Management And General$46,434ManagementAndGeneralAmt
Fundraising$18,818FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,376,301TotalAmt
Program Services$2,694,648ProgramServicesAmt
Management And General$676,842ManagementAndGeneralAmt
Fundraising$4,811FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$234,472TotalAmt
Program Services$219,642ProgramServicesAmt
Management And General$14,478ManagementAndGeneralAmt
Fundraising$352FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$215,890TotalAmt
Program Services$195,383ProgramServicesAmt
Management And General$20,430ManagementAndGeneralAmt
Fundraising$77FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$6TotalAmt
Program Services$5ProgramServicesAmt
Management And General$1ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,734,566TotalAmt
Program Services$1,568,655ProgramServicesAmt
Management And General$163,826ManagementAndGeneralAmt
Fundraising$2,085FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$140,400TotalAmt
Program Services$132,649ProgramServicesAmt
Management And General$7,476ManagementAndGeneralAmt
Fundraising$275FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
SUBCONTRACTS$6,329,013$6,329,013
RESEARCH SUPPLIES$2,916,192$2,911,484$4,550$158
POSTAGE/BANK FEES/DUES/$472,927$430,317$48,102-$5,492
LAB/CLINICAL/TECH SVS$211,253$213,137-$1,774-$110

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total-$132,655TotalAmt
Program Services$2,596ProgramServicesAmt
Management And General-$135,378ManagementAndGeneralAmt
Fundraising$127FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$34,598,034TotalAmt
Program Services$31,208,929ProgramServicesAmt
Management And General$3,280,816ManagementAndGeneralAmt
Fundraising$108,289FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$900BOYAmt
EOY$900EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,821,525BOYAmt
EOY$7,477,919EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$6,350,215BOYAmt
EOY$5,132,568EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$90,152BOYAmt
EOY$87,320EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$93,078BOYAmt
EOY$82,353EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$376,070BOYAmt
EOY$683,015EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$23,459,656LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$16,239,233LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$8,421,037BOYAmt
EOY$7,220,423EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
EOY$25,766,290EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$35,655BOYAmt
EOY$182,312EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$46,656BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$21,235,288BOYAmt
EOY$46,633,100EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,876,733BOYAmt
EOY$3,620,735EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$4,824,725BOYAmt
EOY$4,765,557EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$616,110BOYAmt
EOY$194,475EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$10,317,568BOYAmt
EOY$8,580,767EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$10,149,200BOYAmt
EOY$37,381,411EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$768,520BOYAmt
EOY$670,922EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,917,720BOYAmt
EOY$38,052,333EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$21,235,288BOYAmt
EOY$46,633,100EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$1,000,438ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$494,444NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$26,628,619OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp (2 entries)

CityCityNmState AbbreviationStateAbbreviationCd
UNIVERSITY OF WASHINGTON MEDICAL CENTER
SEATTLEWA
OREGON HEALTH SCIENCE UNIVERSITY
PORTLANDOR

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$11,549,091OtherCostOrOtherBasisAmt
Depreciation$6,540,296DepreciationAmt
Book Value$5,008,795BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$11,056,755OtherCostOrOtherBasisAmt
Depreciation$8,926,600DepreciationAmt
Book Value$2,130,155BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$853,810OtherCostOrOtherBasisAmt
Depreciation$772,337DepreciationAmt
Book Value$81,473BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$7,220,423TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENT LIABILITYDesc
Amt$194,475Amt
FieldValueIRS element (for citing)
Total Liability$194,475TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$64,133,304TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$494,444NetUnrealizedGainsInvstAmt
Other Revenue$2,265,198OtherRevenueAmt
Revenue Not Reported$1,770,754RevenueNotReportedAmt
Revenue Subtotal$62,362,550RevenueSubtotalAmt
Other Revenues Not Included-$26,764,078OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$26,764,078RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$35,598,472TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$36,998,691TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$2,400,657OtherExpensesIncludedAmt
Expenses Not Reported$2,400,657ExpensesNotReportedAmt
Expenses Subtotal$34,598,034ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$34,598,034TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 2D - OTHER ADJUSTMENTS:RENTAL EXPENSES 2,265,198.
PART XI, LINE 4B - OTHER ADJUSTMENTS:LOSS FROM SALE OF ASSETS -135,459. BOOK/TAX DIFFERENCE ON INVESTMENT IN 307 WESTLAKE -26,628,619.
PART XII, LINE 2D - OTHER ADJUSTMENTS:RENTAL EXPENSES 2,265,198. LOSS FROM SALE OF ASSETS 135,459.

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFICPROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$947
EAST ASIA AND THE PACIFICPROGRAM SERVICESSUB-AWARD$48,272
EUROPE (INCLUDING ICELAND & GREENLANDPROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$2,895
EUROPE (INCLUDING ICELAND & GREENLAND)PROGRAM SERVICESSUB-AWARD$91,291
EUROPE (INCLUDING ICELAND & GREENLAND)PROGRAM SERVICESSUB-AWARD$15,554
MIDDLE EAST AND NORTH AFRICAPROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$309
NORTH AMERICA (CANADA AND MEXICO)PROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$3,324
SOUTH ASIAPROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$1,550
SUB-SAHARAN AFRICAPROGRAM SERVICESTRAVEL/MEETING/CONFERENCE$3,055
SUB-SAHARAN AFRICAPROGRAM SERVICESSUB-AWARD$178,499
SUB-SAHARAN AFRICAPROGRAM SERVICESRESEARCH$74,337
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$164,142SubtotalSpentAmt
Continuation Spent$255,891ContinuationSpentAmt
Total Spent$420,033TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3:FormAndLineReferenceDesc
ExplanationSEATTLE BIOMEDICAL RESEARCH INSTITUTE DOES NOT MAINTAIN ANY FOREIGN OFFICES. THE INSTITUTE'S SUB-CONTRACTORS ARE PERFORMING RESEARCH ON BEHALF OF THE ORGANIZATION AROUND THE WORLD, THE ACCRUAL METHOD OF ACCOUNTING IS USED TO ACCOUNT FOR EXPENDITURES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E Expnss0WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Independent ConsultantYes (X)IndependentConsultantInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ALAN ADEREM PHD
PRESIDENT$318,268$0$0$0$0$0$26,000$0$12,899$0$357,167$0$0$0
KEN STUART PHD
PRESIDENT EMERITUS/ TRUSTEE$294,519$0$0$0$0$0$26,000$0$6,500$0$327,019$0$0$0
RANDALL HASSLER
COO/VP$188,034$0$0$0$0$0$19,237$0$9,400$0$216,671$0$0$0
LOUIS COFFMAN
SR. VP-STRATEGY/ BUSINESS DEVELOPMEN$272,354$0$0$0$0$0$27,500$0$11,702$0$311,556$0$0$0
STEFAN KAPPE PHD
PRINCIPAL INVESTIGATOR$187,468$0$0$0$0$0$17,875$0$9,870$0$215,213$0$0$0
PETER MYLER PHD
PRINCIPAL INVESTIGATOR$160,892$0$0$0$0$0$16,812$0$11,423$0$189,127$0$0$0
LEONIDAS STAMATATOS PHD
PRINCIPAL INVESTIGATOR$187,974$0$0$0$0$0$18,749$0$5,396$0$212,119$0$0$0
SUSAN P BROWN
VP ADVANCEMENT$162,141$0$0$0$0$0$0$0$0$0$162,141$0$0$0
JOHN D AITCHISON
PRINCIPAL INVESTIGATOR$161,284$0$0$0$0$0$16,590$0$12,657$0$190,531$0$0$0
RUOBING WANG
PRINCIPAL INVESTIGATOR$151,415$0$0$0$0$0$15,178$0$7,259$0$173,852$0$0$0
MALCOLM J GARDNER
PRINCIPAL INVESTIGATOR$147,017$0$0$0$0$0$14,735$0$7,263$0$169,015$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 1AFormAndLineReferenceDesc
ExplanationFIRST CLASS TRAVEL IS PERMITTED IF ALLOWABLE UNDER AN AWARD AND/OR THE DIFFERENTIAL IN PRICE IS PAID FOR OUT OF NON-GRANT FUNDS.ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp

FieldValueIRS element (for citing)
PersonSTEFAN KAPPEPersonNm
Relationship With OrgPART VRelationshipWithOrgTxt
Loan PurposePART VLoanPurposeTxt
Loan From OrganizationYes (X)LoanFromOrganizationInd
Original Principal$80,000OriginalPrincipalAmt
Balance Due$82,353BalanceDueAmt
Default0DefaultInd
Board Or Committee ApprovalYes (1)BoardOrCommitteeApprovalInd
Written AgreementYes (1)WrittenAgreementInd
FieldValueIRS element (for citing)
Total Balance Due$82,353TotalBalanceDueAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART IIFormAndLineReferenceDesc
ExplanationSTEFAN KAPPE IS EMPLOYED AS A PRINCIPAL INVESTIGATOR FOR THE ENTITY. THE PURPOSE OF THE LOAN IS NOT RESTRICTED TO A SPECIFIC PURPOSE.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1THE BOARD CAN DELEGATE AUTHORITY TO THE EXECUTIVE COMMITTEE OR OTHER SUBCOMMITTEES (E.G. FINANCE) HOWEVER MOST DECISIONS COME TO THE FULL BOARD FOR ACTION AFTER VETTING AT THE COMMITTEE LEVEL. THERE ARE NO MATERIAL DIFFERENCES AMONG MEMBERS OF THE BOARD. THERE ARE TWO NON-INDEPENDANT VOTING MEMBERS OF THE BOARD WHO ARE TRUSTEES.
FORM 990, PART VI, SECTION B, LINE 11THE RETURN WILL BE REVIEWED IN DETAIL BY THE DIRECTOR OF FINANCE. IN ADDITION, THE 990 WILL BE PRESENTED TO THE FINANCE AND AUDIT COMMITTEE. A FINAL DRAFT WILL BE ELECTRONICALLY SENT TO ALL TRUSTEES OF THE INSTITUTE. OUR BOARD LIAISON WILL MONITOR THE DISTRIBUTION OF THE RETURN AND WILL COLLECT COMMENTS AND RESPONSES AND REPORT THESE TO THE DIRECTOR OF FINANCE PROMPTLY. ANY PERTINENT RESPONSES WILL BE ADDRESSED AND RESOLVED BEFORE THE FINAL TAX RETURN IS FILED.
FORM 990, PART VI, SECTION B, LINE 12CEACH TRUSTEE (AND ALL KEY EMPLOYEES) AND MEMBERS OF A COMMITTEE WITH BOARD DELEGATED POWERS SHALL ANNUALLY SIGN A STATEMENT WHICH AFFIRMS THAT SUCH PERSON HAS RECIEVED A COPY OF THE CONFLICT OF INTEREST POLICY, HAS READ AND UNDERSTANDS THE POLICY, AND AGREES TO COMPLY WITH THE POLICY. IF ANY KNOW CONFLICTS ARISE, THEY ARE SENT TO THE EXECUTIVE COMMITTEE FOR RESOLUTION. A FOLLOWUP TO THE LEADERSHIP TEAM THEN OCCURS, IF NEEDED. PROCEDURE: 1. DUTY TO DISCLOSE: IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTANCE AND NATURE OF HIS/HER FINANCIAL INTEREST TO THE EXECUTIVE COMMITTEE OF THE BOARD OF TRUSTEES PRIOR TO CONSIDERATION OF THE PROPOSED TRANSACTION OR ARRANGEMENT AND MUST NOT ENTER INTO ANY ARRANGEMENT WHERE THERE IS AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST WITHOUT EXECUTIVE COMMITTEE APPROVAL. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS: AFTER DISCLOSURE OF THE FINANCIAL INTEREST, THE INTERESTED PERSON SHALL RECUSE HIMSELF/HERSELF WHILE THE FINANCIAL INTEREST IS DISCUSSED AND VOTED UPON. THE EXECUTIVE COMMITTEE SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST: A. THE EXECUTIVE COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. B. AFTER EXERCISING DUE DILLIGENCE, THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER SEATTLE BIOMED CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. C. IF A MORE ADVANTAGOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY ATTAINABLE UNDER CIRCUMSTANCES THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST, THE BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED MEMBERS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE INSTITUTE'S BEST INTEREST AND FOR ITS OWN BENEFIT AND WHETHER THE TRANSACTION IS FAIR AND REASONABLE TO THE INSTITUTE AND SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT IN CONFORMITY WITH SUCH DETERMINATION. 4. VIOLATIONS OF THE CONFLICTS OF INTEREST POLICY: A. IF THE BOARD, A COMMITTEE, THE INSTITUTE'S STAFF OR A TRUSTEE HAS REASONABLE CAUSE TO BELIEVE THAT A TRUSTEE OR A COMMITTEE MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL INFORM THE MEMBER OF THE BASIS FOR SUCH BELIEF AND AFFORD THE MEMBER THE OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING THE RESPONSE OF THE MEMBER AND MAKING SUCH FURTHER INVESTIGATION AS MAY BE WARRANTED IN THE CIRCUMSTANCES, THE EXECUTIVE BOARD DETERMINES THAT THE MEMBER HAS, IN FACT, FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION PLANNING AND REVIEW TAKES PLACE ANNUALLY. HUMAN RESOURCES PROVIDES MARKET DATA FOR EACH POSITION IN THE INSTITUTE. FOR SENIOR LEADERSHIP POSITIONS, SPECIFICALLY KEY EMPLOYEES, AN OUTSIDE COMPENSATION CONSULTANT BENCHMARKS THESE POSITIONS AND PROVIDES DATA AND ANALYSIS, WHICH ALLOWS THE ORGANIZATION'S HUMAN RESOURCE DEPARTMENT TO ESTABLISH A PAY RANGE FOR EACH OF THESE ROLES AT OUR INSTITUTE. THE HUMAN RESOURCE DEPARTMENT ALSO GATHERS INDUSTRY-SPECIFIC INFORMATION FROM OUR PEERS TO VALIDATE THE SURVEY INFORMATION AND TO ENSURE THAT WE REMAIN COMPETITIVE WITH OUR COMPENSATION. THIS INFORMATION IS SOMETIMES GATHERED FROM LOCAL PEER ORGANIZATIONS IN OUR INDUSTRY AND/OR FROM PEER ORGANIZATIONS WHO ARE PART OF THE ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES (AIRI). THE MOST RECENT COMPENSATION REVIEW OF SENIOR POSITIONS (PRIOR TO JUNE 30, 2015) TOOK PLACE IN JANUARY 2012.
FORM 990, PART VI, SECTION C, LINE 19THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9:BOOK/TAX DIFFERENCE ON INVESTMENT IN 307 WESTLAKE 26,628,619.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.